Role of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer disease

Nature Medicine

Volumn 11, Issue 9, 2005, Pages 959-965

  Wu, Zhenhua ^a   Guo, Huang ^a,b   Chow, Nienwen ^b   Sallstrom, Jan ^b   Bell, Robert D ^b   Deane, Rashid ^a   Brooks, Andrew I ^a   Kanagala, Suhasini ^b   Rubio, Anna ^b   Sagare, Abhay ^a   Liu, Dong ^a   Li, Fang ^b   Armstrong, Don ^b,c   Gasiewicz, Thomas ^d   Zidovetzki, Raphael ^b,c   Song, Xiaomei ^a   Hofman, Florence ^b,e   Zlokovic, Berislav V ^a,b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b Socratech Research Laboratories   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; BRAIN PROTEIN; HOMEODOMAIN PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AFX1; TRANSCRIPTION FACTOR GAX; UNCLASSIFIED DRUG; VIRUS VECTOR;

ALZHEIMER DISEASE; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLOOD BRAIN BARRIER; BRAIN; BRAIN BLOOD FLOW; BRAIN CAPILLARY; BRAIN HYPOXIA; BRAIN LEVEL; CAPILLARY DENSITY; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE DELETION; GENE EXPRESSION; GENE FUNCTION; GENE REPRESSION; GENE SILENCING; GENE TRANSFER; GENETIC TRANSCRIPTION; HOMEOBOX; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; REGULATORY MECHANISM; STIMULATION;

ALZHEIMER DISEASE; ANIMALS; APOPTOSIS; BRAIN; CELLS, CULTURED; ENDOTHELIAL CELLS; FRONTAL LOBE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENES, HOMEOBOX; HOMEODOMAIN PROTEINS; HUMANS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; NEOVASCULARIZATION, PHYSIOLOGIC;

ANIMALIA;

EID: 24744457932     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1287     Document Type: Article

References (49)

1. Alzheimer, A. Uber eine eigenartig Erkrankung der Hirnrinde. Allg. Z. Psychiatrie Psych. Ger. Med 64, 146-148 (1907).
2. Zlokovic, B.V. Neurovascular mechanisms of Alzheimer's neurodegeneration. Trends Neurosci. 28, 202-208 (2005).
3. de la Torre, J.C. Alzheimer's disease is a vasocognopathy: a new term to describe its nature. Neurol. Res. 26, 517-524 (2004).
4. Gorelick, P.B. Risk factors for vascular dementia and Alzheimer's disease. Stroke 35, 2620-2622 (2004).
5. Casserly, I. & Topol, E. Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins. Lancet 363, 1139-1146 (2004).
6. Roher, A.E. et al. Atherosclerosis of cerebral arteries in Alzheimer's disease. Stroke 35, 2623-2627 (2004).
7. Greenberg, S.M. et al. Amyloid angiopathy-related vascular cognitive impairment. Stroke 35, 2616-2619 (2004).
8. Bailey, T.L. et al. The nature and effects of cortical microvascular pathology in aging and Alzheimer's disease. Neurol. Res. 26, 573-578 (2004).
9. Farkas, E. & Luiten, P.G. Cerebral microvascular pathology in aging and Alzheimer's disease. Prog. Neurobiol. 64, 575-611 (2001).
10. Paris, D. et al. Impaired angiogenesis in a transgenic mouse model of cerebral amyloidosis. Neurosci. Lett. 366, 80-85 (2004).
11. Paris, D. et al. Inhibition of angiogenesis by Aβ peptides. Angiogenesis 7, 75-78 (2004).
12. Carmeliet, P. & Jain, R.K. Angiogenesis in cancer and other diseases. Nat. Med. 9, 653-660 (2003).
13. Shibata, M. et al. Clearance of Alzheimer's amyloid-β 1-40 peptide from brain by LDL receptor related protein-1 at the blood-brain barrier. J. Clin. Invest. 106, 1489-1499 (2000).
14. Deane, R. et al. LRP/amyloid β-peptide interaction mediates differential brain efflux of Aβ isoforms. Neuron 43, 333-344 (2004).
15. Tanzi, R.E. et al. Clearance of Alzheimer's Aβ peptides: the many roads to perdition. Neuron 43, 605-608 (2004).
16. Iadecola, C. Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat. Rev. Neurosci. 5, 347-360 (2004).
17. Iadecola, C. et al. SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein. Nat. Neurosci. 2, 157-161 (1999).
18. Gorski, D.H. et al. Molecular cloning of a diverged homeobox gene that is rapidly downregulated during the Go/G1 transition in vascular smooth muscle cells. Mol. Cell. Biol. 13, 3722-3733 (1993).
19. Gorski, D.H. & Walsh, K. Control of vascular cell differentiation by homeobox transcription factors. Trends Cardiovasc. Med. 13, 213-220 (2003).
20. Tang, T.T. et al. The Forkhead transcription factor AFX activates apoptosis by induction of the BCL-6 transcriptional repressor. J. Biol. Chem. 277, 14255-14265 (2002).
21. Bu, G. & Marzolo, M.P. Role of RAP in the biogenesis of lipoprotein receptors. Trends Cardiovasc. Med. 10, 148-155 (2000).
22. Mankoo, B.S. et al. Mox2 is a component of the genetic hierarchy controlling limb muscle development. Nature 400, 69-73 (1999).
23. Braak, H. & Braak, E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol. (Berl.) 82, 239-259 (1991).
24. Hyman, B.T. & Trojanowski, J.Q. Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Regan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J. Neuropathol. Exp. Neurol. 56, 1095-1097 (1997).
25. Baldi, P. & Long, A.D. A Bayesian framework for the analysis of microarray expression data: regularized t-test and statistical inferences of gene changes. Bioinformatics 17, 509-519 (2001).
26. Liu, D., Jia, H., Holmes, D.I., Stannard, A. & Zachary, I. Vascular endothelial growth factor regulated gene expression in endothelial cells: KDR-mediated induction of Egr3 and the related nuclear receptors Nur77, Nurr1, and Nor1. Arterioscler. Thromb. Vasc. Biol. 23, 2002-2007 (2003).
27. Citron, B.A., Suo, Z., SantaCruz, K. & Davies, P.J.A. Protein crosslinking, tissue transglutaminase, alternative splicing and neurodegeneration. Neurochem. Intl. 40, 69-78 (2002).
28. Kozak, M. Initiation of translation in prokaryotes and eukaryotes. Gene 234, 187-208 (1999).
29. Davis, G.E., Pintar, Allen, K.A., Salazar, R. & Maxwell, S.A. Matrix metalloproteinase-1 and -9 activation by plasmin regulates a novel endothelial cell-mediated mechanism of collagen gel contraction and capillary tube regression in three-dimensional collagen matrices. J. Cell Sci. 114, 917-930 (2001).
30. Gorski, D.H. & Leal, A.J. Inhibition of endothelial cell activation by the homeobox gene Gax. J. Surg. Res. 111, 91-99 (2003).
31. Patel, S., Leal, A.D. & Gorski, D.H. The homeobox gene Gax inhibits angiogenesis through inhibition of nuclear factor-κB-dependent endothelial cell gene expression. Cancer Res. 65, 1414-1424 (2005).
32. Perlman, H. et al. Bax-mediated cell death by the Gax homeoprotein requires mitogen activation but is independent of cell cycle activity. EMBO J. 17, 3576-3586 (1998).
33. LaRue, B. et al. Method for measurement of the blood-brain barrier permeability in the perfused mouse brain: application to amyloid β-peptide in wild type and Alzheimer's Tg2576 mice. J. Neurosci. Methods 138, 233-242 (2004).
34. LaManna, J.C., Chavez, J.C. & Pichiule, P. Structural and functional adaptation to hypoxia in the rat brain. J. Exp. Biol. 207, 3163-3169 (2004).
35. Kawarabayashi, T. et al. Age dependent changes in brain, CSF, and plasma amyloid-β in the Tg2576 transgenic mouse model of Alzheimer's disease. J. Neurosci. 21, 372-381 (2001).
36. Fryer, J.D. et al. Apoliprotein E markedly facilitates age-dependent cerebral amyloid angiopathy an spontaneous hemorrhage in amyloid precursor protein transgenic mice. J. Neurosci. 23, 7889-7896 (2003).
37. Herz, J. & Marschang, P. Coaxing the LDL receptor family into the blood. Cell 112, 289-292 (2003).
38. Lahvis, G.P. et al. Portosystemic shunting and persistent fetal vascular structures in aryl hydrocarbon receptor-deficient mice. Proc. Natl. Acad. Sci. USA 97, 10442-10447 (2000).
39. Li, Y., Lul, W., Marazolo, M.P. & Bu, G. Differential functions of members of the low density lipoprotein receptor family suggested by their distinct endoytosis rates. J. Biol. Chem. 276, 18000-18006 (2001).
40. Andres, V., Fisher, S., Wearsch, P. & Walsh, K. Regulation of Gax homeobox gene transcription by a combination of positive factors including myocyte-specific enhancer factor 2. Mol. Cell. Biol. 15, 4272-4281 (1995).
41. Saito, T. et al. Angiotensin II suppresses growth arrest specific homeobox (Gax) expression via redox-sensitive mitogen-activated protein kinase (MAPK). Reg. Peptides 127, 159-167 (2005).
42. Atwood, C.S. et al. Amyloid-β: a chameleon walking in two worlds: a review of the trophic and toxic properties of amyloid-beta. Brain Res. Rev. 43, 1-16 (2003).
43. Hermann, D.M. et al. Relationship between metabolic dysfunctions, gene responses and delayed cell death after mild focal cerebral ischemia in mice. Neuroscience 104, 947-955 (2001).
44. Iscove, N.N. et al. Representation is faithfully preserved in global cDNA amplified exponentially from sub-picogram quantities of mRNA. Nat. Biotechnol. 20, 940-943 (2002).
45. Holland, P.M., Abramson, R.D., Watson, R. & Gelfand, D.H. Detection of specific polymerase chain reaction product by utilizing the 5′,3′ exonuclease activity of Thermus aquaticus DNA polymerase. Proc. Natl. Acad. Sci. USA 88, 7276-7280 (1991).
46. Mackic, J.B. et al. Human blood-brain barrier receptors for Alzheimer's amyloid-β. J. Clin. Invest. 102, 734-743 (1998).
47. Russell, W.C. et al. Update on adenovirus and its vectors. J. Gen.Virol. 81, 2573-2604 (2000).
48. Wu, Z., Hofman, F.M. & Zlokovic, B.V. A simple method for isolation and characterization of mouse brain microvascular endothelial cells. J. Neurosci. Methods 130, 53-63 (2003).
49. Witzenbichler, B. et al. Regulation of smooth muscle cell migration and integrin expression by the Gax transcription factor. J. Clin. Invest. 104, 1469-1480 (1999).